Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens, N. Burgess-Brown, Shisong Jiang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 460
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 95
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 92
Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches
Yaxian Wang, Xinyang Zhong, Xuefeng He, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 41
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6845-6862
Open Access | Times Cited: 38
Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines
Zhe Sun, Xiaodong Sun, Zhanwei Chen, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 63
Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy
Lei Lei, Dennis Huang, Huile Gao, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 62
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer
Ryan A. Bottens, Tohru Yamada
Cancers (2022) Vol. 14, Iss. 22, pp. 5546-5546
Open Access | Times Cited: 45
Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery
Natashya Falcone, Menekşe Ermis, Dilara Goksu Tamay, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Closed Access | Times Cited: 24
Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery
Suhair Sunoqrot, Sara A. Abdel Gaber, Razan Abujaber, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 4998-5019
Closed Access | Times Cited: 13
Personalized cancer vaccine design using AI-powered technologies
Anant Kumar, Shriniket Dixit, Kathiravan Srinivasan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Engineering Saccharomyces cerevisiae for medical applications
Carla Maneira, Alexandre Chamas, Gerald Lackner
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
Mariam Oladejo, Wyatt Paulishak, Laurence M. Wood
Seminars in Cancer Biology (2022) Vol. 88, pp. 81-95
Open Access | Times Cited: 35
Application of lipid-based nanoparticles in cancer immunotherapy
Zhongkun Zhang, Siyu Yao, Yingwen Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Nanovaccine Displaying Immunodominant T Cell Epitopes of Fibroblast Activation Protein Is Effective Against Desmoplastic Tumors
Hocheol Shin, Yujin Kim, Sangyong Jon
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10337-10352
Closed Access | Times Cited: 16
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Skylar T. Chuang, Brandon Conklin, Joshua B. Stein, et al.
Nano Convergence (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 27
The influence of component structural arrangement on peptide vaccine immunogenicity
Nedaa Alharbi, Mariusz Skwarczyński, István Tóth
Biotechnology Advances (2022) Vol. 60, pp. 108029-108029
Closed Access | Times Cited: 24
Improving the efficacy of peptide vaccines in cancer immunotherapy
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110721-110721
Closed Access | Times Cited: 15
Advances in Cancer Vaccine Research
Nian Liu, Xiangyu Xiao, Zi-qiang Zhang, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 11, pp. 5999-6023
Closed Access | Times Cited: 15
Current Status and Challenges of Vaccination Therapy for Glioblastoma
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression
Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 603-603
Open Access | Times Cited: 5
The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines
Antonia D’Aniello, Alessandra Del Bene, Salvatore Mottola, et al.
Journal of Peptide Science (2024) Vol. 30, Iss. 8
Closed Access | Times Cited: 5
Cancer Vaccines in the Immunotherapy Era: Promise and Potential
Chaitenya Verma, Vishakha Anand Pawar, Shivani Srivastava, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1783-1783
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top